VERAXA Biotech AG, an emerging leader in designing novel cancer therapies, announced the initiation of cell line development for its lead BiTAC® T-cell engager (BiTAC-TCE)...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Halozyme Therapeutics, Inc. announced the appointment of David Ramsay as President Drug Delivery, effective June 30, 2026.
In this newly created role, Mr. Ramsay will...
Zymo Research Corp., a global life sciences company developing molecular tools for research and translational applications, has joined the Blood Profiling Atlas in Cancer...
LabGenius Therapeutics, a pioneer in machine learning (ML)-driven antibody engineering, has entered into a multi-year research collaboration, option, and license agreement with global chemical...
